Effects of empagliflozin on liver fat in patients with metabolic dysfunction–associated steatotic liver disease without diabetes mellitus: A randomized, double-blind, placebo-controlled trial.

Details

Language :

English

ISSN :

02709139

Volume :

80

Issue :

4

Database :

Complementary Index

Journal :

Hepatology (02709139)

Publication Type :

Academic Journal

Accession number :

180992313

Full Text :

https://doi.org/10.1097/HEP.0000000000000855